Vesalius Biocapital Partners

Vesalius Biocapital Partners

Strassen, Canton of Luxembourgvesaliusbiocapital.com

Overview

Vesalius Biocapital Partners is a European life sciences venture capital investor. They invest in companies active in human health through venture capital funds raised since 2007, focusing on therapeutics, medical devices & diagnostics and eHealth / mHealth. They finance both early stage companies and corporate spin-offs with more mature assets.

Year Founded

2007

Portfolio Companies

9

Investments

CompanyDateStageLead
NutriumSep 2025Series ALead
InflammatixSep 2024Series ECo-investor
CatalYmJul 2024Series DCo-investor
Tonic AppMar 2024Series ACo-investor
Memo TherapeuticsNov 2023Series CCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersStrassen, Canton of Luxembourg
Year Founded2007

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.